INNOVATIONS in pharmacy is an open-access, web-based journal. Works accepted for publication are posted on the website immediately upon final acceptance. There are no submission or article processing charges. As an open-access journal, INNOVATIONS in pharmacy does not require authors to transfer full copyright ownership to the journal as a condition of publication. Authors will grant a nonexclusive license in their work to INNOVATIONS in pharmacy and the University of Minnesota Libraries. Such a license gives INNOVATIONS in pharmacy and the Libraries the necessary rights to publish, distribute, archive, and preserve the work. However, since the license is non-exclusive, all rights will still belong to the creator, who may make any use they wish and may grant other licenses as desired. The result of this license agreement is that the author, INNOVATIONS in pharmacy, and the Libraries will each have broad rights to the work.
Anyone may submit an original article to be considered for publication in INNOVATIONS in pharmacy provided the author(s) owns the copyright to the work being submitted or is authorized by the copyright owner or owners to submit the article. Authors are the initial owners of the copyrights to their works (an exception in the non-academic world to this might exist if the authors have, as a condition of employment, agreed to transfer copyright to their employer).
Submitted articles cannot have been previously published or forthcoming in an archival journal or book (print or electronic). Please note: "publication" in a working-paper series does not constitute prior publication. In addition, by submitting material to INNOVATIONS in pharmacy, the author is stipulating that the material is not currently under review at another journal (electronic or print) and that they will not submit the material to another journal (electronic or print) until the completion of the editorial decision process at INNOVATIONS in pharmacy. If you have concerns about the submission terms for INNOVATIONS in pharmacy, please email the editors at schom010@umn.edu.
Authorship confers credit and implies responsibility and accountability. INNOVATIONS conforms to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals of the ICJME. To that end, authorship is based on four criteria: 1) substantial contributions to the conception or design of the work or the acquisition, analysis, or interpretation of data for the work; AND 2) drafting the work or revising it critically for important intellectual content, AND 3) final approval of the version to be published, AND 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All those designated as authors should meet all four criteria, and all who meet the criteria should be designated as authors. Those who do not meet all four criteria should be acknowledged.
Works are invited in the following topic areas:
A wide variety of article types are accepted for peer-reviewed publication:
The cover page of a work should include the title, authors and institutions, abstract (250-300 words), and keywords. In addition, please include statements related to acknowledgments, funding/support, and conflicts of interest. If there is nothing to disclose in any of these categories, please list the category and state none (e.g., Conflicts of Interest: None). All submissions to Pharmacy Practice & Practice-Based Research are to have numbered lines and pages. All submissions to Education should follow the section's descriptions.
There are no page limits for manuscripts. For ease in communicating, the manuscript should include page numbers. Tables and Figures should be included in the manuscript document. If this is problematic, they may be submitted as separate files. It is preferred that references be identified by number and listed in numerical order using a standard style (e.g., AMA). Upon receipt, the editorial team will coordinate peer review using national and international experts. Feedback regarding the status of the work will be given within 45 days of submission.
As an open-access, web-based journal, we encourage authors to be innovative and creative in disseminating their work. We gladly accept works that include web links, appendices, novel methods, and creative supporting materials.
In exchange for publishing the work in Innovations, the authors represent and warrant that they are the sole creators of the work and owners of all rights, titles, and interests in and to the work, including the complete and undivided copyright interest to the work. The authors represent and warrant that they have not granted any person any interest, including permissions, licenses, or assignments, in the work that conflicts with the rights, titles, and interests granted here. To each author's knowledge, the work does not infringe the copyright or other intellectual property rights of any person nor defame, slander, or libel any person nor invade the privacy or other like rights of a person. The authors represent and warrant that they either have express written permission to any third-party content used in their submission to or that they have a good-faith belief that the works they are using are in the public domain, that their use is fair use, or that they are using works under an appropriate Creative Commons (or other open-content) license.
Authors must declare any conflicts of interest that may affect the information, research, analysis, or interpretation presented in the work. The cover page of the work should disclose any conflicts of interest. A conflict of interest exists when professional judgment concerning a primary interest (such as the validity of the research) may be influenced by secondary interests (such as financial gain). If there are none to declare, please indicate “Conflicts of Interest: None” on the work's cover page. Additional information on Conflicts of Interest is available for downloading through the International Committee of Medical Journal Editors (ICMJE). Although INNOVATIONS does not require this form, it may assist authors in identifying conflicts: http://www.icmje.org/conflicts-of-interest/.
The author affirms that an Institutional Review Board (IRB) has reviewed research projects which involve human subjects to ensure that two broad standards are upheld: first, that subjects are not placed at undue risk; second, that they give uncoerced, informed consent to their participation.
When animals are used in research, the journal requires written confirmation that the research was approved by an institutional animal care and use committee. The article should contain a description of the research protocols and methods used and the research standards set by the institutional or national guides for the care and use of laboratory animals.
If you have questions or concerns about any of the above statements, please email the editors at schom010@umn.edu.
All articles published in Innovations in Pharmacy are distributed with a Creative Commons Noncommercial Attribution (CC BY-NC 4.0) license meaning that authors hold the copyright to their work. This also means that users have the right to share or adapt the article, as long as the author(s) and source are cited and the use is for noncommercial purposes. Permission is not needed for these noncommercial uses.
For permission for other uses or questions about use, please contact the author(s) or editors at schom010@umn.edu.
Users of the website and/or software agree not to misuse the service or software in any way.
The failure to exercise or enforce any right or provision in the policies or the Submission Agreement does not constitute a waiver of such right or provision. If any term of the Submission Agreement or these policies is found to be invalid, the parties nevertheless agree that the court should endeavor to give effect to the parties' intentions as reflected in the provision, and the other provisions of the Submission Agreement and these policies remain in full force and effect. These policies and the Submission Agreement constitute the entire agreement between and the Author(s) regarding submission of the Article.
Innovations in Pharmacy provides immediate open access to its content, which means that all content is freely available without charge to the user or their institution. This also means that Innovations in Pharmacy does not charge article processing fees. All articles are licensed under a Creative Commons Noncommercial Attribution license (CC BY-NC 4.0)
The copyright of each article belongs to the author(s) and grants each author the right to deposit the article in their institutional repository or any suitable subject repository, provided they do not contravene the requirements of the CC license associated with the article.
Contact Publishing Services | Acceptable Use of IT Resources
The copyright of these individual works published by the University of Minnesota Libraries Publishing remains with the original creator or editorial team. For uses beyond those covered by law or the Creative Commons license, permission to reuse should be sought directly from the copyright owner listed on each article.
